DK0963985T3 - Di- eller triaza-spiro[4,5]decanderivater - Google Patents

Di- eller triaza-spiro[4,5]decanderivater

Info

Publication number
DK0963985T3
DK0963985T3 DK99110954T DK99110954T DK0963985T3 DK 0963985 T3 DK0963985 T3 DK 0963985T3 DK 99110954 T DK99110954 T DK 99110954T DK 99110954 T DK99110954 T DK 99110954T DK 0963985 T3 DK0963985 T3 DK 0963985T3
Authority
DK
Denmark
Prior art keywords
triaza
spiro
decane derivatives
decane
derivatives
Prior art date
Application number
DK99110954T
Other languages
English (en)
Inventor
Geo Adam
Andrea Cesura
Francois Jenck
Sabine Kolczewski
Stephan Roever
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0963985T3 publication Critical patent/DK0963985T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99110954T 1998-06-12 1999-06-07 Di- eller triaza-spiro[4,5]decanderivater DK0963985T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110803 1998-06-12

Publications (1)

Publication Number Publication Date
DK0963985T3 true DK0963985T3 (da) 2003-06-23

Family

ID=8232113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99110954T DK0963985T3 (da) 1998-06-12 1999-06-07 Di- eller triaza-spiro[4,5]decanderivater

Country Status (30)

Country Link
US (1) US6642247B2 (da)
EP (1) EP0963985B1 (da)
JP (1) JP3369123B2 (da)
KR (1) KR100393311B1 (da)
CN (2) CN1110497C (da)
AR (1) AR019860A1 (da)
AT (1) ATE234302T1 (da)
AU (1) AU752835B2 (da)
BR (1) BR9902653A (da)
CA (1) CA2274201C (da)
CO (1) CO5040061A1 (da)
CZ (1) CZ291323B6 (da)
DE (1) DE69905798T2 (da)
DK (1) DK0963985T3 (da)
ES (1) ES2194402T3 (da)
HR (1) HRP990187A2 (da)
HU (1) HUP9901910A3 (da)
ID (1) ID23306A (da)
IL (1) IL130375A0 (da)
MA (1) MA26645A1 (da)
NO (1) NO312591B1 (da)
NZ (1) NZ336226A (da)
PE (1) PE20000540A1 (da)
PL (1) PL333693A1 (da)
PT (1) PT963985E (da)
SG (1) SG83135A1 (da)
TR (1) TR199901380A3 (da)
TW (1) TW434241B (da)
YU (1) YU26799A (da)
ZA (2) ZA993853B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69923744T2 (de) * 1998-10-23 2006-02-23 Pfizer Inc. 1,3,8-Triazaspiro[4,5] decanon Verbindungen als orl1-receptor Agonisten
EP1491212B1 (en) 2002-03-29 2012-08-08 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
DE102004014296A1 (de) * 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen
KR100662191B1 (ko) 2004-12-23 2006-12-27 엘지이노텍 주식회사 질화물 반도체 발광소자 및 그 제조방법
JP5313865B2 (ja) 2007-03-01 2013-10-09 田辺三菱製薬株式会社 ベンゾイミダゾール化合物およびその医薬用途
TW201016675A (en) 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
CN109503582A (zh) * 2018-12-17 2019-03-22 上海合全药物研发有限公司 顺式螺[哌啶并-4,1＇-吡咯并[3,4-c]吡咯]-1-甲酸叔丁酯的合成方法
US20230348493A1 (en) * 2020-05-12 2023-11-02 Beijing Greatway Pharmaceutical Technology Co., Ltd. Compound for adjusting activity of nmda receptor, and pharmaceutical composition and use thereof
KR20220022988A (ko) 2020-08-20 2022-03-02 제트스타 주식회사 트랙터용 써레

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63208844A (ja) * 1987-02-26 1988-08-30 Konica Corp 有機着色物質の光褪色防止方法
US5221675A (en) * 1989-12-15 1993-06-22 Abbott Laboratories Aza-spirocyclic compounds that enhance cholinergic neurotransmission
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Also Published As

Publication number Publication date
HU9901910D0 (en) 1999-08-30
YU26799A (sh) 2002-03-18
CZ203999A3 (cs) 2000-03-15
CZ291323B6 (cs) 2003-02-12
TR199901380A2 (xx) 2001-01-22
NO312591B1 (no) 2002-06-03
CN1244528A (zh) 2000-02-16
HUP9901910A2 (hu) 2000-04-28
AR019860A1 (es) 2002-03-20
CA2274201C (en) 2010-02-09
EP0963985A3 (en) 2001-01-24
DE69905798D1 (de) 2003-04-17
DE69905798T2 (de) 2004-02-12
SG83135A1 (en) 2001-09-18
CA2274201A1 (en) 1999-12-12
KR100393311B1 (ko) 2003-08-02
PT963985E (pt) 2003-06-30
BR9902653A (pt) 2000-05-02
US20030176701A1 (en) 2003-09-18
IL130375A0 (en) 2000-06-01
PL333693A1 (en) 1999-12-20
JP3369123B2 (ja) 2003-01-20
ZA993853B (en) 1999-12-13
CN1110497C (zh) 2003-06-04
EP0963985B1 (en) 2003-03-12
ID23306A (id) 2000-04-05
TR199901380A3 (tr) 2001-01-22
CO5040061A1 (es) 2001-05-29
AU752835B2 (en) 2002-10-03
HUP9901910A3 (en) 2001-11-28
NO992876L (no) 1999-12-13
US6642247B2 (en) 2003-11-04
ES2194402T3 (es) 2003-11-16
AU3498699A (en) 1999-12-23
TW434241B (en) 2001-05-16
CN1242367A (zh) 2000-01-26
CN1229377C (zh) 2005-11-30
ZA993901B (en) 1999-12-13
MA26645A1 (fr) 2004-12-20
NO992876D0 (no) 1999-06-11
ATE234302T1 (de) 2003-03-15
EP0963985A2 (en) 1999-12-15
NZ336226A (en) 2000-10-27
KR20000006135A (ko) 2000-01-25
PE20000540A1 (es) 2000-07-15
HRP990187A2 (en) 2000-02-29
JP2000026466A (ja) 2000-01-25

Similar Documents

Publication Publication Date Title
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
ATE240327T1 (de) 1,2-annelierte chinolinderivate
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
PT930302E (pt) Derivados de benzo-sulfona
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
PT1104422E (pt) Derivados de fenilxantina
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
PT928790E (pt) Derivados de tiazolo
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
PT922050E (pt) Derivados de 3-descladinose-2,3-anidroeritromicina
DK1140835T3 (da) 3,3-biarylpiperidin- og 2,2-biarylmorpholon-derivater
ATE204279T1 (de) Diaza-spiro(3,5)nonan-derivate
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
PT1056716E (pt) Derivados de ciclo-hexanodiolo
DK0963985T3 (da) Di- eller triaza-spiro[4,5]decanderivater
ATE233253T1 (de) Chromanderivate
PT1123283E (pt) Derivados de tiazole
BR9505177A (pt) Derivados de ciclolignan antineoplásticos
BR9701404A (pt) Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol
PT928793E (pt) Derivados de tiazol
PT1065205E (pt) Derivados heteroaromaticos